Reference
Medsafe. Empagliflozin: advise patients on the risk of ketoacidosis. Prescriber Update 42: No. 3, Sep 2021. Available from: URL: http://www.medsafe.govt.nz/profs/PUArticles/PDF/Prescriber_Update_Vol%2042_No.3_September_2021.pdf
Rights and permissions
About this article
Cite this article
Diabetic ketoacidosis or Fournier's gangrene with empagliflozin. Reactions Weekly 1873, 2 (2021). https://doi.org/10.1007/s40278-021-02425-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-02425-6